Dinesh Saralaya

4.6k total citations
32 papers, 445 citations indexed

About

Dinesh Saralaya is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Dinesh Saralaya has authored 32 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 19 papers in Physiology and 5 papers in Surgery. Recurrent topics in Dinesh Saralaya's work include Asthma and respiratory diseases (17 papers), Inhalation and Respiratory Drug Delivery (13 papers) and Respiratory and Cough-Related Research (7 papers). Dinesh Saralaya is often cited by papers focused on Asthma and respiratory diseases (17 papers), Inhalation and Respiratory Drug Delivery (13 papers) and Respiratory and Cough-Related Research (7 papers). Dinesh Saralaya collaborates with scholars based in United Kingdom, United States and Spain. Dinesh Saralaya's co-authors include Henry Chrystyn, Harold Hosker, Philip Chetcuti, John Stephenson, Peter M Turkington, Mark W. Elliott, Monica Sircar, J. Charles Talbot, Quamar Bismil and Robert Niven and has published in prestigious journals such as Gut, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

Dinesh Saralaya

28 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dinesh Saralaya United Kingdom 11 270 269 65 52 39 32 445
Lynn J. Kepnes United States 9 159 0.6× 83 0.3× 113 1.7× 67 1.3× 5 0.1× 14 444
Laura Tenero Italy 13 176 0.7× 150 0.6× 33 0.5× 12 0.2× 13 0.3× 44 421
Christer Carenfelt Sweden 16 299 1.1× 170 0.6× 142 2.2× 109 2.1× 131 3.4× 20 691
Moussa Riachy Lebanon 10 87 0.3× 78 0.3× 30 0.5× 25 0.5× 19 0.5× 33 246
K Murree-Allen Australia 9 229 0.8× 328 1.2× 25 0.4× 23 0.4× 11 0.3× 17 458
Ada Luz Andreu Spain 9 116 0.4× 134 0.5× 20 0.3× 49 0.9× 16 0.4× 21 280
Hanna L. Roiha Switzerland 8 115 0.4× 194 0.7× 41 0.6× 105 2.0× 4 0.1× 8 416
Εpameinondas Zakynthinos Greece 11 113 0.4× 116 0.4× 16 0.2× 60 1.2× 10 0.3× 21 390
G E Erhabor Nigeria 8 68 0.3× 58 0.2× 30 0.5× 82 1.6× 25 0.6× 29 291
Facundo Nogueira Argentina 7 170 0.6× 89 0.3× 15 0.2× 21 0.4× 34 0.9× 16 328

Countries citing papers authored by Dinesh Saralaya

Since Specialization
Citations

This map shows the geographic impact of Dinesh Saralaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinesh Saralaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinesh Saralaya more than expected).

Fields of papers citing papers by Dinesh Saralaya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dinesh Saralaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinesh Saralaya. The network helps show where Dinesh Saralaya may publish in the future.

Co-authorship network of co-authors of Dinesh Saralaya

This figure shows the co-authorship network connecting the top 25 collaborators of Dinesh Saralaya. A scholar is included among the top collaborators of Dinesh Saralaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dinesh Saralaya. Dinesh Saralaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Washko, George R., et al.. (2025). Effect of dupilumab on small airways measured by airway oscillometry in VESTIGE. Journal of Allergy and Clinical Immunology. 156(5). 1209–1218. 2 indexed citations
2.
Whitaker, Paul, et al.. (2022). Musculoskeletal tuberculosis in Bradford. Bone & Joint Open. 3(5). 432–440. 2 indexed citations
3.
Singh, Dave, Jim M. Wild, Dinesh Saralaya, et al.. (2022). Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial. Respiratory Research. 23(1). 26–26. 8 indexed citations
4.
Chrystyn, Henry, et al.. (2021). Investigating the Accuracy of the Digihaler, a New Electronic Multidose Dry-Powder Inhaler, in Measuring Inhalation Parameters. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 35(3). 166–177. 19 indexed citations
5.
Busse, William W., Jorge Máspero, Dinesh Saralaya, et al.. (2018). Dupilumab improves SNOT-22 scores in asthma patients with chronic rhinosinusitis or nasal polypsosis (CRS/NP) in LIBERTY ASTHMA QUEST. Ghent University Academic Bibliography (Ghent University). PA1125–PA1125. 12 indexed citations
6.
Niven, Robert, Dinesh Saralaya, Rekha Chaudhuri, et al.. (2016). Impact of omalizumab on treatment of severe allergic asthma in UK clinical practice: a UK multicentre observational study (the APEX II study). BMJ Open. 6(8). e011857–e011857. 51 indexed citations
7.
Marı́n, José M., Kai Michael Beeh, L Schaper, et al.. (2016). Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING). International Journal of COPD. Volume 11. 1425–1434. 13 indexed citations
8.
9.
Chetcuti, Philip, et al.. (2014). The Inhalation Characteristics of Patients When They Use Different Dry Powder Inhalers. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28(1). 35–42. 90 indexed citations
10.
Saralaya, Dinesh, et al.. (2014). Lung function response to omalizumab in severe allergic asthma patients in UK clinical practice: APEX II study. European Respiratory Journal. 44(Suppl 58). P3480–P3480.
11.
Campbell, Jessica, et al.. (2013). Improved Metered Dose Inhaler Technique When a Coordination Cap Is Used. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 27(3). 193–199. 19 indexed citations
12.
Chetcuti, Philip, et al.. (2013). Inhalation characteristics with Spiromax® (S) versus Turbuhaler® (T) dry powder inhalers (DPI) in healthy adults (HA) and in patients with asthma (A) or COPD. European Respiratory Journal. 42(Suppl 57). P711–P711. 3 indexed citations
13.
Saralaya, Dinesh, et al.. (2013). Real life effectiveness of omalizumab in severe allergic asthma, does the IgE level matter? A Bradford experience. European Respiratory Journal. 42(Suppl 57). P918–P918. 1 indexed citations
14.
Hegade, Vinod S., Ruchit Sood, Dinesh Saralaya, & Sulleman Moreea. (2013). Pulmonary complications of treatment with pegylated interferon for hepatitis C infection-Two case reports. Annals of Hepatology. 12(4). 461–465. 7 indexed citations
15.
16.
Ryan, Dermot, Feargal J. Ryan, Dinesh Saralaya, et al.. (2012). P276 The Impact of the Optimum Patient Care Service on Outcomes for Adult Asthmatic Patients: Abstract P276 Table 1. Thorax. 67(Suppl 2). A186.1–A186.
17.
Britton, Mark, Timothy R. Howes, Dinesh Saralaya, et al.. (2011). Real-life effectiveness of omalizumab in patients with severe persistent allergic (IgE-mediated) asthma: Pooled data from 3 UK centres. European Respiratory Journal. 38(Suppl 55). p273–p273. 2 indexed citations
18.
Chetcuti, Philip, et al.. (2011). Objective measurement of inhalation profiles in patients using metered dose inhalers (MDIs). European Respiratory Journal. 38(Suppl 55). p838–p838. 1 indexed citations
19.
Bothamley, Graham, Michelle E. Kruijshaar, Heinke Kunst, et al.. (2011). Tuberculosis in UK cities: workload and effectiveness of tuberculosis control programmes. BMC Public Health. 11(1). 896–896. 14 indexed citations
20.
Saralaya, Dinesh. (2004). Serum and sputum concentrations following the oral administration of linezolid in adult patients with cystic fibrosis. Journal of Antimicrobial Chemotherapy. 53(2). 325–328. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lynn J. Kepnes Breakdown of academic impact, for papers by Laura Tenero Breakdown of academic impact, for papers by Christer Carenfelt Breakdown of academic impact, for papers by Moussa Riachy Breakdown of academic impact, for papers by K Murree-Allen Breakdown of academic impact, for papers by Ada Luz Andreu Breakdown of academic impact, for papers by Hanna L. Roiha Breakdown of academic impact, for papers by Εpameinondas Zakynthinos Breakdown of academic impact, for papers by G E Erhabor Breakdown of academic impact, for papers by Facundo Nogueira
Rankless by CCL
2026